SIPC Sipp Industries

Sipp Industries Announces New Beverage Development and Distribution Initiatives

Company to launch Blue Bear Vodka and exploring entry into the CBD and THC infused beverage markets

Costa Mesa, California--(Newsfile Corp. - February 19, 2021) -  Sipp Industries, Inc. (OTC PINK: SIPC), a multifaceted corporation specializing in manufacturing and distribution of commercial and consumer products, and the producer of craft hemp-infused beer and other fine alcohol and non-alcoholic beverages, announces new business opportunities in the spirits and cannabis beverage space.

Sipp Industries has been working with a local distillery to produce a line of craft spirits. The line under consideration includes a vodka, gin and whiskey. The products will be produced and launched in phases throughout this year.



To view an enhanced version of this graphic, please visit:

The Company is scheduled to launch Blue Bear Vodka early next month as its first product. Blue Bear is a craft vodka distilled from cane, registering at 40% alcohol by volume or 80 proof. It is distilled six times and available in 750 mL bottles.

The label for the Blue Bear Vodka has been approved and the Company is proceeding to finalize the packaging with production to immediately followed. Additional information regarding the vodka and launch will be provided in the next few weeks.

The Company is also in discussion to arrange for the product distribution starting with the distillery's local and Elite Beverage's national distributors. The vodka will be available in retail as well as online stores.

The Company remains in contact with the Food and Drug Administration ("FDA") and the Alcohol Tobacco Tax and Trade Bureau ("TTB") regarding its Cannabidiol ("CBD") Beer recipe. This is still pending approval with both parties until further regulatory clarity is made by the government which is expected sometime this year. As federal cannabis laws continue to evolve, Sipp Industries is positioned for quick recipe approval which remains a high priority for the Company.

To capitalize on the burgeoning cannabis beverage industry, the Company is continuing its discussions with a partner company to develop non-alcoholic beers infused with CBD and THC. These new products will not need approval from the TTB and will be initially targeted to medical marijuana dispensaries in the Southwest region. The Company has received strong interest from several dispensaries to carry these two product concepts.

Earlier this year, Molson Coors announced the launch of its first CBD beverages in Colorado and U.S. Constellation-backed Canopy Growth is set to enter the legal cannabis markets in California and Illinois later this year.

In addition to developing its own brands, Sipp Industries will continue to work with partners Elite Beverage and Green Cures and Botanical Distribution ("Green Cures") for broader distribution of Tequila Comisario and Contagin. The Company will remain a distribution partner of Green Cures for Contagin, but brand manufacturing and ownership will remain under Green Cures.

About Sipp Industries, Inc.

Sipp Industries is a multifaceted corporation that specializes in manufacturing and distribution of commercial and consumer products, and the producers of craft hemp-infused beer and other fine alcohol and non-alcoholic beverages.

Website:
Facebook:
Twitter:

Forward Looking Statements:

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the Company and its management team.

Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations. Some or all of the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control.

Contact:
Ted Jorgensen
Sipp Industries, Inc.
Investor Relations

949.220.0435

To view the source version of this press release, please visit

EN
19/02/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sipp Industries

 PRESS RELEASE

SIPP Industries Appoints Adam Graziano as New CEO to Lead Next Chapter...

SIPP Industries Appoints Adam Graziano as New CEO to Lead Next Chapter of Growth and Innovation COSTA MESA, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce the appointment of Adam Graziano as the new Chief Executive Officer, effective immediately.Jakob Jorgensen, the former CEO of SIPP Industries, will remain a business consultant while also joining Calypso Pharmaceuticals as their new CEO. Mr. Jorge...

 PRESS RELEASE

SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmac...

SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma COSTA MESA, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development agreement with Calypso Pharmaceuticals. The aim is to create a nano-emulsified topical formulation in collaboration with AVEINA, SIPP's wellness-focused brand specializing in nanotech...

 PRESS RELEASE

SIPP Industries Announces Strategic Acquisition of Revenue Share in Ca...

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries COSTA MESA, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Sipp Industries, Inc. (OTC: SIPC), a leading player in the cannabis and hemp industries, announces its strategic acquisition of revenue share in Calypso Pharmaceuticals, a Texas-based company renowned for its innovative products and proprietary technology in the cannabis and hemp sectors. The acquisition marks a significant milestone in SIPP Industries' mission to expand its product portfolio an...

 PRESS RELEASE

Sipp Industries Announces Distribution Agreement for Patented SinuSave...

Sipp Industries Announces Distribution Agreement for Patented SinuSave® CBD Nasal Spray COSTA MESA, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sipp Industries, Inc. (OTC: SIPC), a trailblazing corporation, renowned for its innovation in the manufacturing and distribution of commercial and consumer products within the cannabis industry, is pleased to announce a distribution agreement with SinuSave® for its SinuSave® CBD Nasal Spray products. SinuSave® CBD Nasal Spray, offering a range of patented CBD nasal spray products in 500mg and 1000mg strengths, is poised to transform the wellnes...

 PRESS RELEASE

Sipp Industries Receives Order for Delta-8 Infused Sauces from Uncle S...

Sipp Industries Receives Order for Delta-8 Infused Sauces from Uncle Stu’s Vape & Smoke Shop Sipp Industries and Uncle Stu’s set to co-sponsor tasting and sampling event in the Greater Chicago area COSTA MESA, CA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Sipp Industries, Inc. (OTC Pink: SIPC), a multifaceted corporation specializing in manufacturing, and distribution of commercial and consumer products in the cannabis industry, announces it has received an initial order for its newly launched Delta-8 (“D8”) infused sauces.  Earlier this year, Sipp Industries launched a new line of D8 infu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch